Regulatory & Legal

New Measure A funds will provide emergency rental aid to thousands of at-risk households, marking a major step in the county's new housing strategy.

A Utah biotech reports promising results for a novel mRNA therapy that makes cancer cells look like measles, setting the stage for crucial animal trials.

An international expert panel endorses an advanced wound therapy, potentially revolutionizing patient recovery and boosting a key player in the med-tech market.

The CT Plan selects DataCT as its independent administrator, a critical step in a sweeping SEC-mandated overhaul of market data set for 2027.

As Missourians face winter energy costs, Ameren offers simple holiday tips that could save up to $70 and inspire year-round efficiency habits.

Facing financial pressure, the U.S. Postal Service is opening its vast delivery network to all shippers, a move that could save the agency and disrupt rivals.

A new report projects 27.5% annual growth for automotive AI, fueled by smart cars, government backing, and a fierce race for market dominance.

The drone taxi market is projected to soar to $3.8 billion by 2032. But can regulators, infrastructure, and public trust keep up with the hype?

CERo Therapeutics reports early safety success and dose escalation in its Phase 1 AML trial for CER-1236, a novel cell therapy for high-risk patients.

New data reveals a novel wound gel is successfully treating conditions previously deemed unhealable, offering hope against chronic wounds and antibiotic resistance.

As Simply Good Foods preps its Q1 report, investors weigh Quest's strong growth against the ongoing struggles of its Atkins brand and market pressures.

A new generation of copper-clad aluminum wire aims to solve construction's biggest headaches, promising cost stability, theft deterrence, and greener builds.

A lawsuit alleges gross negligence by Holiday Inn and Airgas after a toxic ammonia leak from a tanker left hotel guests with horrific, life-altering injuries.

A new study reveals a tissue allograft, AmchoPlast™, triples healing rates for diabetic foot ulcers, offering a major breakthrough for a common complication.

From crypto pivots to robotics rallies, companies are making bold moves. But as narratives shift, discerning hype from reality is more crucial than ever.

DPL hires Brad Mendenhall to expand its platform as RIAs increasingly embrace commission-free insurance for holistic, fiduciary-first financial planning.

A music legend's donation fuels a new model for equitable recovery, helping Black communities in LA rebuild not just homes, but generational wealth.

New data shows Vyriad's VV169 eliminated myeloma in mice without severe toxicity, signaling a potential shift to safer, scalable 'off-the-shelf' CAR T.

Amid rising food insecurity, US Foods delivered nearly $12.5M in aid, powered by a 70% surge in employee volunteerism and new strategic programs.

Princess Cruises will air every FIFA World Cup match at sea. Is this a strategic play to win over sports fans and dominate the luxury travel market?